Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.12	20.15	21.01
Graham Fair Price	-7.80	244790.44	265508.64
PEG	-183.79	-0.74	-0.26
Price/Book	-7.42	0.67	0.72
Price/Cash Flow	186.25	-27.66	9.66
Prices/Earnings	17.81	13.55	11.50
Price/Sales	-2.73	0.69	0.71
Price/FCF	186.25	-27.66	9.66
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.73	0.21	0.19
Operating Margin	27.33	0.05	0.04
ROA	-20.05	< 0.005	< 0.005
ROE	0.02	0.01	-21.41
ROIC	0.02	0.02	-13.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.06	29.71
Dividends QOQ	0.51	-1.00	97.89
EBIT QOQ	-0.25	0.26	5.54
EPS QOQ	-0.44	-0.18	58.49
FCF QOQ	0.03	-1.34	5074.30
Revenue QOQ	-0.02	-0.01	51.28
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.67	46.34	8.62
Days Sales Outstanding (DSO)	40.11	38.76	-3.37
Inventory Turnover	2.11	1.94	-7.94
Debt/Capitalization	0.57	0.58	1.92
Quick Ratio	0.58	0.54	-6.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	446324.91	464187.12	4.00
Cash	126508.77	132903.03	5.05
Capex	-22168.81	-11573.59	47.79
Free Cash Flow	33427.93	-11243.87	-66.36
Revenue	454930.66	450344.96	-1.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.95	1.03	8.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.52	13.55	0.26
Naive Interpretation	Member

06 - Financial Health · Bad

Rating